Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2011

01.01.2011 | Preclinical study

Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells

verfasst von: Michael J. Willhauck, Dennis J. O`Kane, Nathalie Wunderlich, Burkhard Göke, Christine Spitzweg

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The sodium iodide symporter (NIS) mediates the active iodide uptake in the thyroid gland as well as lactating breast tissue. Recently, we reported significant stimulation of all-trans retinoic acid (atRA)-induced NIS expression in the estrogen-receptor positive human breast cancer cell line MCF-7 by dexamethasone (Dex) in vitro and in vivo, which might offer the potential to image and treat breast cancer with radioiodine. In this study, based on its known interaction with the pregnane-X-receptor (PXR) forming a heterodimer with the retinoid-X-receptor (RXR), we examined the effect of carbamazepine (CBZ), a potent activator of PXR, on atRA-induced NIS expression and therapeutic efficacy of 131I in MCF-7 cells. For this purpose, functional NIS expression in MCF-7 cells was examined by iodide uptake assay, quantitative real-time PCR as well as Western blot analysis, followed by investigation of 131I cytotoxicity in vitro after incubation with CBZ (4, 25, 100 μM) in the presence of atRA (1 μM) with or without Dex (100 nM). Incubation with CBZ stimulated atRA-induced iodide accumulation up to twofold in a concentration-dependent manner, while atRA/Dex-stimulated iodide uptake was further stimulated up to 1.5-fold by additional CBZ treatment based on significantly increased NIS mRNA and protein levels. This stimulatory effect of CBZ was shown to be dependent on the PI3K-Akt pathway without involvement of mTOR. In contrast, treatment with CBZ alone had no effect on functional NIS expression. Moreover, selective cytotoxicity of 131I was significantly increased from approximately 20% in MCF-7 cells treated with atRA alone to 50% after treatment with CBZ in the presence of atRA, which was further enhanced to 90% after combined treatment with atRA/Dex/CBZ. In conclusion, CBZ represents another potent stimulator of atRA-induced functional NIS expression resulting in an enhanced selective killing effect of 131I in MCF-7 breast cancer cells.
Literatur
1.
Zurück zum Zitat Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Rev 24:48–77CrossRef Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Rev 24:48–77CrossRef
2.
Zurück zum Zitat Spitzweg C, Morris JC (2002) The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol 57:559–574CrossRef Spitzweg C, Morris JC (2002) The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol 57:559–574CrossRef
3.
Zurück zum Zitat Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N (2009) The Na+/I- symporter mediates active iodide uptake in the intestine. Am J Physiol Cell Physiol 296:C654–C662CrossRefPubMed Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N (2009) The Na+/I- symporter mediates active iodide uptake in the intestine. Am J Physiol Cell Physiol 296:C654–C662CrossRefPubMed
4.
Zurück zum Zitat Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871–878CrossRefPubMed Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871–878CrossRefPubMed
5.
Zurück zum Zitat Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn I-M (2001) Correlation between 99mTc-pertechnetate uptakes and expression of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol 28:829–834CrossRefPubMed Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn I-M (2001) Correlation between 99mTc-pertechnetate uptakes and expression of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol 28:829–834CrossRefPubMed
6.
Zurück zum Zitat Renier C, Yao C, Goris M, Ghosh M, Katznelson L, Nowles K, Gambhir SS, Wapnir I (2009) Endogenous NIS expression in triple-negative breast cancers. Ann Surg Oncol 16:962–968CrossRefPubMed Renier C, Yao C, Goris M, Ghosh M, Katznelson L, Nowles K, Gambhir SS, Wapnir I (2009) Endogenous NIS expression in triple-negative breast cancers. Ann Surg Oncol 16:962–968CrossRefPubMed
7.
Zurück zum Zitat Rudnicka L, Sinczak A, Szybinski P, Huszno B, Stachura J (2003) Expression of the Na(+)/I(−) symporter in invasive ductal breast cancer. Folia Histochem Cytobiol 41:37–40PubMed Rudnicka L, Sinczak A, Szybinski P, Huszno B, Stachura J (2003) Expression of the Na(+)/I(−) symporter in invasive ductal breast cancer. Folia Histochem Cytobiol 41:37–40PubMed
8.
Zurück zum Zitat Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N (2004) The Na +/I− symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res 10:4294–4302CrossRefPubMed Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N (2004) The Na +/I− symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res 10:4294–4302CrossRefPubMed
9.
Zurück zum Zitat Kogai T, Kanamoto Y, Che LH, Taki K, Moatamed F, Schultz JJ, Brent GA (2004) Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodine uptake in mouse breast cancer models. Cancer Res 64:415–422CrossRefPubMed Kogai T, Kanamoto Y, Che LH, Taki K, Moatamed F, Schultz JJ, Brent GA (2004) Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodine uptake in mouse breast cancer models. Cancer Res 64:415–422CrossRefPubMed
10.
Zurück zum Zitat Kogai T, Kanamoto Y, Li AI, Che LH, Ohashi E, Taki K, Chandraratna RA, Saito T, Brent GA (2005) Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology 146:3059–3069CrossRefPubMed Kogai T, Kanamoto Y, Li AI, Che LH, Ohashi E, Taki K, Chandraratna RA, Saito T, Brent GA (2005) Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology 146:3059–3069CrossRefPubMed
11.
Zurück zum Zitat Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA (2000) Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97:8519–8524CrossRefPubMed Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA (2000) Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97:8519–8524CrossRefPubMed
12.
Zurück zum Zitat Kogai T, Taki K, Brent GA (2006) Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13:797–826CrossRefPubMed Kogai T, Taki K, Brent GA (2006) Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13:797–826CrossRefPubMed
13.
Zurück zum Zitat Dohan O, De la Vieja A, Carrasco N (2006) Hydrocortisone and purinergic signaling stimulate NIS-mediated iodide transport in breast cancer cells. Mol Endocrinol 20:1121–1137CrossRefPubMed Dohan O, De la Vieja A, Carrasco N (2006) Hydrocortisone and purinergic signaling stimulate NIS-mediated iodide transport in breast cancer cells. Mol Endocrinol 20:1121–1137CrossRefPubMed
14.
Zurück zum Zitat Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C (2006) Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab 91:69–78CrossRefPubMed Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C (2006) Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab 91:69–78CrossRefPubMed
15.
Zurück zum Zitat Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C (2008) Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat 109:263–272CrossRefPubMed Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C (2008) Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat 109:263–272CrossRefPubMed
16.
Zurück zum Zitat Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y, Brent GA (2008) Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 93:1884–1892CrossRefPubMed Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y, Brent GA (2008) Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 93:1884–1892CrossRefPubMed
17.
Zurück zum Zitat Ohashi E, Kogai T, Kagechika H, Brent GA (2009) Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res 69:3443–3450CrossRefPubMed Ohashi E, Kogai T, Kagechika H, Brent GA (2009) Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res 69:3443–3450CrossRefPubMed
18.
Zurück zum Zitat Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP (1998) Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806–8811CrossRefPubMed Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP (1998) Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806–8811CrossRefPubMed
19.
Zurück zum Zitat Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687–702CrossRefPubMed Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687–702CrossRefPubMed
20.
Zurück zum Zitat Tanosaki S, Ikezoe T, Heaney A, Said JW, Dan K, Akashi M, Koeffler HP (2003) Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res Treat 79:335–345CrossRefPubMed Tanosaki S, Ikezoe T, Heaney A, Said JW, Dan K, Akashi M, Koeffler HP (2003) Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res Treat 79:335–345CrossRefPubMed
21.
Zurück zum Zitat Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E, Gan LS (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795–804CrossRefPubMed Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E, Gan LS (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795–804CrossRefPubMed
22.
Zurück zum Zitat Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221CrossRefPubMed Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221CrossRefPubMed
23.
Zurück zum Zitat Weiss SJ, Philip NJ, Grollmann EF (1984) Iodine transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114:1090–1098CrossRefPubMed Weiss SJ, Philip NJ, Grollmann EF (1984) Iodine transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114:1090–1098CrossRefPubMed
24.
Zurück zum Zitat Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC (1999) Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol 163:495–504CrossRefPubMed Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC (1999) Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol 163:495–504CrossRefPubMed
25.
Zurück zum Zitat Mandell RB, Mandell LZ, Link CJ (1999) Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 59:661–668PubMed Mandell RB, Mandell LZ, Link CJ (1999) Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 59:661–668PubMed
26.
Zurück zum Zitat Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15:5256–5267PubMed Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15:5256–5267PubMed
27.
Zurück zum Zitat Brown-Grant K (1957) The iodide concentrating mechanism of the mammary gland. J Physiol 135:644–654PubMed Brown-Grant K (1957) The iodide concentrating mechanism of the mammary gland. J Physiol 135:644–654PubMed
28.
Zurück zum Zitat Knostman KA, Cho JY, Ryu KY, Lin X, McCubrey JA, Hla T, Liu CH, Di Carlo E, Keri R, Zhang M, Hwang DY, Kisseberth WC, Capen CC, Jhiang SM (2004) Signaling through 3′,5′-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer. J Clin Endocrinol Metab 89:5196–5203CrossRefPubMed Knostman KA, Cho JY, Ryu KY, Lin X, McCubrey JA, Hla T, Liu CH, Di Carlo E, Keri R, Zhang M, Hwang DY, Kisseberth WC, Capen CC, Jhiang SM (2004) Signaling through 3′,5′-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer. J Clin Endocrinol Metab 89:5196–5203CrossRefPubMed
29.
Zurück zum Zitat Conde I, Lobo MV, Zamora J, Perez J, Gonzalez FJ, Alba E, Fraile B, Paniagua R, Arenas MI (2008) Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer 8:174CrossRefPubMed Conde I, Lobo MV, Zamora J, Perez J, Gonzalez FJ, Alba E, Fraile B, Paniagua R, Arenas MI (2008) Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer 8:174CrossRefPubMed
30.
Zurück zum Zitat Blumberg B, Evans RM (1998) Orphan nuclear receptors—new ligands and new possibilities. Genes Dev 12:3149–3155CrossRefPubMed Blumberg B, Evans RM (1998) Orphan nuclear receptors—new ligands and new possibilities. Genes Dev 12:3149–3155CrossRefPubMed
Metadaten
Titel
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells
verfasst von
Michael J. Willhauck
Dennis J. O`Kane
Nathalie Wunderlich
Burkhard Göke
Christine Spitzweg
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0835-x

Weitere Artikel der Ausgabe 2/2011

Breast Cancer Research and Treatment 2/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.